LifeVantage finalizes purchase of LoveBiome, broadening influence in direct sales, microbiome health, and wellness sector

LifeVantage Corporation, a pioneer in nutrigenomics, has announced a significant move in the health supplement industry by acquiring LoveBiome, a direct sales company dedicated to microbiome care and wellness solutions.

LoveBiome, a leader in the emerging microbiome health sector, focuses on the connection between gut health and overall wellness. Their innovative P84 product regulates, repairs, and restores the gut and microbiome, setting them apart in the market.

The acquisition is expected to close by mid-October, upon satisfaction of customary closing conditions and regulatory requirements. LifeVantage will acquire LoveBiome's critical operating assets essential to the microbiome health business.

The transaction structure includes the retention of key LoveBiome personnel, with founder and CEO Kelly Olsen, and other team members joining LifeVantage. This move is expected to strengthen LifeVantage's position in the direct sales industry with engaged leaders and broadened community reach.

The acquisition is expected to expand LifeVantage's product portfolio with Activation differentiation in gut and microbiome health. This aligns with LifeVantage's focus on activating optimal health processes throughout the body.

LifeVantage Corporation's products work with the unique biology of the body to help it make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, and the MindBody GLP-1 System™.

The acquisition is projected to be accretive to Adjusted EPS and Adjusted EBITDA in the first year, with additional synergy opportunity. It is expected to grow LifeVantage's consultant network in key markets including the US, Taiwan, and Europe.

LoveBiome's expertise in microbiome science complements LifeVantage's existing portfolio, further solidifying their position in the health supplement market. The global gut health supplement market is projected to grow from $14.4 billion in 2025 to $32.4 billion by 2035, registering a robust CAGR of 8.4%.

While the search results do not specify which founders and team members from LifeVantage and LoveBiome will be retained or will join LifeVantage after the merger, the acquisition is a testament to both companies' commitment to improving health and wellness through innovative solutions.